We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 15, 2021

Incidence of Symptomatic Skeletal Events and Bone-Modifying Agent Use in Castration-Resistant Prostate Cancer

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Real-World Incidence of Symptomatic Skeletal Events and Bone-Modifying Agent Use in Castration-Resistant Prostate Cancer – An Australian Multi-Centre Observational Study
Eur. J. Cancer 2021 Jul 31;[EPub Ahead of Print], A Anton, S Wong, J Shapiro, A Weickhardt, A Azad, EM Kwan, L Spain, A Gunjur, J Torres, P Parente, F Parnis, J Goh, MC Semira, P Gibbs, B Tran, C Pezaro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading